Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Alberto Pinsino
  • Antonia Gaudig
  • Francesco Castagna
  • Giulio M Mondellini
  • Barry J McDonnell
  • Eric J Stöhr
  • John Cockcroft
  • Robert L Kormos
  • Gabriel T Sayer
  • Nir Uriel
  • Yoshifumi Naka
  • Koji Takeda
  • Melana Yuzefpolskaya
  • Paolo C Colombo

Research Organisations

External Research Organisations

  • University of Münster
  • Columbia University Irving Medical Center
  • Cardiff Metropolitan University
  • Abbott Neuromodulation
  • Montefiore Medical Center
  • Weill Cornell Medicine (WCM)
View graph of relations

Details

Original languageEnglish
Pages (from-to)e18-e20
JournalASAIO Journal
Volume70
Issue number2
Publication statusPublished - 11 Jul 2023

Abstract

Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. 1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. 1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, 4 and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.

Keywords

    Doppler, automated blood pressure monitor, blood pressure, left ventricular assist device

ASJC Scopus subject areas

Cite this

Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients. / Pinsino, Alberto; Gaudig, Antonia; Castagna, Francesco et al.
In: ASAIO Journal, Vol. 70, No. 2, 11.07.2023, p. e18-e20.

Research output: Contribution to journalArticleResearchpeer review

Pinsino, A, Gaudig, A, Castagna, F, Mondellini, GM, McDonnell, BJ, Stöhr, EJ, Cockcroft, J, Kormos, RL, Sayer, GT, Uriel, N, Naka, Y, Takeda, K, Yuzefpolskaya, M & Colombo, PC 2023, 'Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients', ASAIO Journal, vol. 70, no. 2, pp. e18-e20. https://doi.org/10.1097/MAT.0000000000002012
Pinsino, A., Gaudig, A., Castagna, F., Mondellini, G. M., McDonnell, B. J., Stöhr, E. J., Cockcroft, J., Kormos, R. L., Sayer, G. T., Uriel, N., Naka, Y., Takeda, K., Yuzefpolskaya, M., & Colombo, P. C. (2023). Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients. ASAIO Journal, 70(2), e18-e20. https://doi.org/10.1097/MAT.0000000000002012
Pinsino A, Gaudig A, Castagna F, Mondellini GM, McDonnell BJ, Stöhr EJ et al. Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients. ASAIO Journal. 2023 Jul 11;70(2):e18-e20. doi: 10.1097/MAT.0000000000002012
Pinsino, Alberto ; Gaudig, Antonia ; Castagna, Francesco et al. / Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients. In: ASAIO Journal. 2023 ; Vol. 70, No. 2. pp. e18-e20.
Download
@article{ed87db24260c469c855a8b4465b43667,
title = "Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients",
abstract = "Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. 1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. 1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, 4 and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.",
keywords = "Doppler, automated blood pressure monitor, blood pressure, left ventricular assist device",
author = "Alberto Pinsino and Antonia Gaudig and Francesco Castagna and Mondellini, {Giulio M} and McDonnell, {Barry J} and St{\"o}hr, {Eric J} and John Cockcroft and Kormos, {Robert L} and Sayer, {Gabriel T} and Nir Uriel and Yoshifumi Naka and Koji Takeda and Melana Yuzefpolskaya and Colombo, {Paolo C}",
note = "Funding Information: Disclosure: R.L.K. is an employee of Abbott; N.U. received grant research support (Abbott and Medtronic) and is a medical advisory board member (Livemetric and Leviticus); P.C.C. received research grant support and consultant (Abbott). The other authors have no conflicts of interest to report. This work was supported from an Abbott Research Grant.",
year = "2023",
month = jul,
day = "11",
doi = "10.1097/MAT.0000000000002012",
language = "English",
volume = "70",
pages = "e18--e20",
journal = "ASAIO Journal",
issn = "0162-1432",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "2",

}

Download

TY - JOUR

T1 - Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients

AU - Pinsino, Alberto

AU - Gaudig, Antonia

AU - Castagna, Francesco

AU - Mondellini, Giulio M

AU - McDonnell, Barry J

AU - Stöhr, Eric J

AU - Cockcroft, John

AU - Kormos, Robert L

AU - Sayer, Gabriel T

AU - Uriel, Nir

AU - Naka, Yoshifumi

AU - Takeda, Koji

AU - Yuzefpolskaya, Melana

AU - Colombo, Paolo C

N1 - Funding Information: Disclosure: R.L.K. is an employee of Abbott; N.U. received grant research support (Abbott and Medtronic) and is a medical advisory board member (Livemetric and Leviticus); P.C.C. received research grant support and consultant (Abbott). The other authors have no conflicts of interest to report. This work was supported from an Abbott Research Grant.

PY - 2023/7/11

Y1 - 2023/7/11

N2 - Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. 1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. 1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, 4 and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.

AB - Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. 1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. 1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, 4 and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.

KW - Doppler

KW - automated blood pressure monitor

KW - blood pressure

KW - left ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=85184345438&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000002012

DO - 10.1097/MAT.0000000000002012

M3 - Article

C2 - 37429021

VL - 70

SP - e18-e20

JO - ASAIO Journal

JF - ASAIO Journal

SN - 0162-1432

IS - 2

ER -

By the same author(s)